Virtus LifeSci Valuation Overview

BBP -- USA Etf  

USD 46.70  0.37  0.80%

Virtus LifeSci Biotech has current Real Value of $46.94 per share. The regular price of the etf is $46.7. At this time the etf appears to be fairly valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 12, Net Asset of 36.96M and Price to Earning of 18.03times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Products ETF is the top ETF in price to sales as compared to similar ETFs. It is rated below average in price to book as compared to similar ETFs fabricating about  0.30  of Price to Book per Price to Sales. The ratio of Price to Sales to Price to Book for Virtus LifeSci Biotech Products ETF is roughly  3.37 

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries
Fairly Valued
July 15, 2018
Market Value
Real Value
Target Odds
Virtus LifeSci is not too risky asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.